Sign in/Register
Seidl CI, Fulga TA, Murphy CL, CRISPR-Cas9 targeting of MMP13 in human chondrocytes leads to significantly reduced levels of the metalloproteinase and enhanced type II collagen accumulation. Osteoarthritis Cartilage 27(1):140-147, (2019). PMID: 30223022
Related
No related products available for this item.
NEWS, ANNOUNCEMENTS, PROMOTIONS AND MORE